StockData
Moderna, Inc. logo

Moderna, Inc. (MRNA) stock

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30537% above fair value
$196.79−10.01 (-4.84%)

Close on Nov 18, 2026Market cap $78.57BP/E –Yield –

Moderna operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Moderna's operating income for the twelve months ending Jun 30, 2026 was -$3.32B. For fiscal 2025 it was -$3.07B. The highest annual figure on record is $13.30B in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.07B–
FY2024Dec 31, 2024-$3.95B–
FY2023Dec 31, 2023-$4.24B-145.0%
FY2022Dec 31, 2022$9.42B-29.2%
FY2021Dec 31, 2021$13.30B–
FY2020Dec 31, 2020-$763.00M–
FY2019Dec 31, 2019-$546.00M–
FY2018Dec 31, 2018-$413.27M–
FY2017Dec 31, 2017-$269.36M–
FY2016Dec 31, 2016-$223.77M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$815.00M–
Q1 FY2026Mar 31, 2026-$1.39B–
Q4 FY2025Dec 31, 2025-$857.00M–
Q3 FY2025Sep 30, 2025-$260.00M–
Q2 FY2025Jun 30, 2025-$907.00M–
Q1 FY2025Mar 31, 2025-$1.05B–
Q4 FY2024Dec 31, 2024-$1.25B-20866.7%
Q3 FY2024Sep 30, 2024-$70.00M–
Q2 FY2024Jun 30, 2024-$1.36B–
Q1 FY2024Mar 31, 2024-$1.27B–
Q4 FY2023Dec 31, 2023$6.00M-99.6%
Q3 FY2023Sep 30, 2023-$2.01B-272.6%
Q2 FY2023Jun 30, 2023-$1.87B-176.3%
Q1 FY2023Mar 31, 2023-$366.00M-108.7%
Q4 FY2022Dec 31, 2022$1.58B-70.8%
Q3 FY2022Sep 30, 2022$1.17B-67.2%
Q2 FY2022Jun 30, 2022$2.45B-20.1%
Q1 FY2022Mar 31, 2022$4.23B+233.9%
Q4 FY2021Dec 31, 2021$5.41B–
Q3 FY2021Sep 30, 2021$3.56B–
Q2 FY2021Jun 30, 2021$3.06B–
Q1 FY2021Mar 31, 2021$1.27B–
Q4 FY2020Dec 31, 2020-$275.00M–
Q3 FY2020Sep 30, 2020-$235.00M–
Q2 FY2020Jun 30, 2020-$122.00M–
Q1 FY2020Mar 31, 2020-$131.00M–
Q4 FY2019Dec 31, 2019-$130.56M–
Q3 FY2019Sep 30, 2019-$130.76M–
Q2 FY2019Jun 30, 2019-$143.71M–
Q1 FY2019Mar 31, 2019-$141.64M–
Q4 FY2018Dec 31, 2018-$153.03M–
Q3 FY2018Sep 30, 2018-$85.82M–
Q2 FY2018Jun 30, 2018-$97.02M–
Q1 FY2018Mar 31, 2018-$77.40M–
Q4 FY2017Dec 31, 2017-$41.83M–
Q3 FY2017Sep 30, 2017-$67.87M–
Q2 FY2017Jun 30, 2017-$94.19M–
Q1 FY2017Mar 31, 2017-$65.46M–

More Moderna figures

See a number that looks wrong?